Cargando…

Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study

BACKGROUND: The incidence of ductal carcinoma in situ (DCIS) has increased markedly in recent decades. In the past, mastectomy was the primary treatment for patients with DCIS, but as with invasive cancer, breast-conserving surgery followed by radiation therapy (RT) has become the standard approach....

Descripción completa

Detalles Bibliográficos
Autores principales: Vidali, Cristiana, Caffo, Orazio, Aristei, Cynthia, Bertoni, Filippo, Bonetta, Alberto, Guenzi, Marina, Iotti, Cinzia, Leonardi, Maria Cristina, Mussari, Salvatore, Neri, Stefano, Pietta, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573934/
https://www.ncbi.nlm.nih.gov/pubmed/23098066
http://dx.doi.org/10.1186/1748-717X-7-177
_version_ 1782259528794898432
author Vidali, Cristiana
Caffo, Orazio
Aristei, Cynthia
Bertoni, Filippo
Bonetta, Alberto
Guenzi, Marina
Iotti, Cinzia
Leonardi, Maria Cristina
Mussari, Salvatore
Neri, Stefano
Pietta, Nicoletta
author_facet Vidali, Cristiana
Caffo, Orazio
Aristei, Cynthia
Bertoni, Filippo
Bonetta, Alberto
Guenzi, Marina
Iotti, Cinzia
Leonardi, Maria Cristina
Mussari, Salvatore
Neri, Stefano
Pietta, Nicoletta
author_sort Vidali, Cristiana
collection PubMed
description BACKGROUND: The incidence of ductal carcinoma in situ (DCIS) has increased markedly in recent decades. In the past, mastectomy was the primary treatment for patients with DCIS, but as with invasive cancer, breast-conserving surgery followed by radiation therapy (RT) has become the standard approach. We present the final results of a multi-institutional retrospective study of an Italian Radiation Oncology Group for the study of conservative treatment of DCIS, characterized by a very long period of accrual, from February 1985 to March 2000, and a median follow-up longer than 11 years. METHODS: A collaborative multi-institutional study was conducted in Italy in 10 Radiation Oncology Departments. A consecutive series of 586 women with DCIS histologically confirmed, treated between February 1985 and March 2000, was retrospectively evaluated. Median age at diagnosis was 55 years (range: 29–84); 32 patients were 40 years old or younger. All women underwent conservative surgery followed by whole breast RT. Irradiation was delivered to the entire breast, for a median total dose of 50 Gy; the tumour bed was boosted in 295 cases (50%) at a median dose of 10 Gy. RESULTS: After a median follow-up of 136 months (range: 16–292 months), 59/586 patients (10%) experienced a local recurrence: invasive in 37 cases, intraductal in 20 and not specified in two. Salvage mastectomy was the treatment of choice in 46 recurrent patients; conservative surgery in 10 and it was unknown in three patients. The incidence of local recurrence was significantly higher in women younger than 40 years (31.3%) (p= 0.0009). Five patients developed distant metastases. Furthermore 40 patients developed a contralateral breast cancer and 31 a second primary tumour in a different site. The 10-year actuarial overall survival (OS) was 95.5% and the 10-year actuarial disease-specific survival (DSS) was 99%. CONCLUSIONS: Our results are consistent with those reported in the literature. In particular it has been defined the importance of young age (40 years or less) as a relevant risk factor for local recurrence. This retrospective multi-institutional Italian study confirms the long term efficacy of breast conserving surgery with RT in women with DCIS.
format Online
Article
Text
id pubmed-3573934
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35739342013-02-16 Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study Vidali, Cristiana Caffo, Orazio Aristei, Cynthia Bertoni, Filippo Bonetta, Alberto Guenzi, Marina Iotti, Cinzia Leonardi, Maria Cristina Mussari, Salvatore Neri, Stefano Pietta, Nicoletta Radiat Oncol Research BACKGROUND: The incidence of ductal carcinoma in situ (DCIS) has increased markedly in recent decades. In the past, mastectomy was the primary treatment for patients with DCIS, but as with invasive cancer, breast-conserving surgery followed by radiation therapy (RT) has become the standard approach. We present the final results of a multi-institutional retrospective study of an Italian Radiation Oncology Group for the study of conservative treatment of DCIS, characterized by a very long period of accrual, from February 1985 to March 2000, and a median follow-up longer than 11 years. METHODS: A collaborative multi-institutional study was conducted in Italy in 10 Radiation Oncology Departments. A consecutive series of 586 women with DCIS histologically confirmed, treated between February 1985 and March 2000, was retrospectively evaluated. Median age at diagnosis was 55 years (range: 29–84); 32 patients were 40 years old or younger. All women underwent conservative surgery followed by whole breast RT. Irradiation was delivered to the entire breast, for a median total dose of 50 Gy; the tumour bed was boosted in 295 cases (50%) at a median dose of 10 Gy. RESULTS: After a median follow-up of 136 months (range: 16–292 months), 59/586 patients (10%) experienced a local recurrence: invasive in 37 cases, intraductal in 20 and not specified in two. Salvage mastectomy was the treatment of choice in 46 recurrent patients; conservative surgery in 10 and it was unknown in three patients. The incidence of local recurrence was significantly higher in women younger than 40 years (31.3%) (p= 0.0009). Five patients developed distant metastases. Furthermore 40 patients developed a contralateral breast cancer and 31 a second primary tumour in a different site. The 10-year actuarial overall survival (OS) was 95.5% and the 10-year actuarial disease-specific survival (DSS) was 99%. CONCLUSIONS: Our results are consistent with those reported in the literature. In particular it has been defined the importance of young age (40 years or less) as a relevant risk factor for local recurrence. This retrospective multi-institutional Italian study confirms the long term efficacy of breast conserving surgery with RT in women with DCIS. BioMed Central 2012-10-25 /pmc/articles/PMC3573934/ /pubmed/23098066 http://dx.doi.org/10.1186/1748-717X-7-177 Text en Copyright ©2012 Vidali et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Vidali, Cristiana
Caffo, Orazio
Aristei, Cynthia
Bertoni, Filippo
Bonetta, Alberto
Guenzi, Marina
Iotti, Cinzia
Leonardi, Maria Cristina
Mussari, Salvatore
Neri, Stefano
Pietta, Nicoletta
Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study
title Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study
title_full Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study
title_fullStr Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study
title_full_unstemmed Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study
title_short Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study
title_sort conservative treatment of breast ductal carcinoma in situ: results of an italian multi-institutional retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573934/
https://www.ncbi.nlm.nih.gov/pubmed/23098066
http://dx.doi.org/10.1186/1748-717X-7-177
work_keys_str_mv AT vidalicristiana conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT caffoorazio conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT aristeicynthia conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT bertonifilippo conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT bonettaalberto conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT guenzimarina conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT iotticinzia conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT leonardimariacristina conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT mussarisalvatore conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT neristefano conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy
AT piettanicoletta conservativetreatmentofbreastductalcarcinomainsituresultsofanitalianmultiinstitutionalretrospectivestudy